Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint
Authors:
- Marcelo FerderMFMarcelo Ferder
- Felipe InserraFIFelipe Inserra
- Leon FerderLFLeon Ferder
Open Access
- 1 March 2009
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 296 (3) , H550-H558
Abstract
Malfunctioning mitochondria strongly participate in the pathogenesis of cardiovascular damage associated with hypertension and other disease conditions. Eukaryotic cells move, assume their shape, resist mechanical stress, accommodate their internal constituents, and transmit signals by relying on the constant remodeling of cytoskeleton filaments. Mitochondrial ATP is needed to support cytoskeletal dynamics. Conversely, mitochondria need to interact with cytoskeletal elements to achieve normal motility, morphology, localization, and function. Extracellular matrix (ECM) quantity and quality influence cellular growth, differentiation, morphology, survival, and mobility. Mitochondria can sense ECM composition changes, and changes in mitochondrial functioning modify the ECM. Maladaptive ECM and cytoskeletal alterations occur in a number of cardiac conditions and in most types of glomerulosclerosis, leading to cardiovascular and renal fibrosis, respectively. Angiotensin II (ANG II), a vasoactive peptide and growth factor, stimulates cytosolic and mitochondrial oxidant production, eventually leading to mitochondrial dysfunction. Also, by inducing integrin/focal adhesion changes, ANG II regulates ECM and cytoskeletal composition and organization and, accordingly, contributes to the pathogenesis of cardiovascular remodeling. ANG II-initiated integrin signaling results in the release of transforming growth factor-β1(TGF-β1), a cytokine that modifies ECM composition and structure, induces reorganization of the cytoskeleton, and modifies mitochondrial function. Therefore, it is possible to hypothesize that the depression of mitochondrial energy metabolism brought about by ANG II is preceded by ANG II-induced integrin signaling and the consequent derangement of the cytoskeletal filament network and/or ECM organization. ANG II-dependent TGF-β1release is a potential link between ANG II, ECM, and cytoskeleton derangements and mitochondrial dysfunction. It is necessary to emphasize that the present hypothesis is among many other plausible explanations for ANG II-mediated mitochondrial dysfunction. A potential limitation of this proposal is that the results compiled here were obtained in different cells, tissues, and/or experimental models.Keywords
This publication has 123 references indexed in Scilit:
- Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, αvβ3-integrin, and TGF-β1 in response to ANG II and high glucoseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Intracellular ANG II directly induces in vitro transcription of TGF-β1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1areceptorsAmerican Journal of Physiology-Cell Physiology, 2008
- Vimentin supports mitochondrial morphology and organizationBiochemical Journal, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardiumThe Journal of Physiology, 2007
- Protective effect of long-term angiotensin II inhibitionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Transgenic MMP-2 expression induces latent cardiac mitochondrial dysfunctionBiochemical and Biophysical Research Communications, 2007
- Insulin resistance and atherosclerosisJournal of Clinical Investigation, 2006
- Mutations in the Heparin Binding Domain of Fibronectin in Cooperation with the V Region Induce Decreases in pp125 Levels Plus Proteoglycan-mediated Apoptosis via CaspasesJournal of Biological Chemistry, 1999
- Angiotensin II Regulates Human Vascular Smooth Muscle α-Actin Gene ExpressionBiochemical and Biophysical Research Communications, 1993